Stockreport

Werewolf Therapeutics: In The Hunt For Success In The Cytokine Space [Seeking Alpha]

Xilio Therapeutics, Inc.  (XLO) 
PDF Xilio Therapeutics out-licensed their modified IL-12 to Gilead, but I wouldn't be surprised if Werewolf Therapeutics also has a competitive modified IL-12, with WTX-330 [Read more]